ENvue Medical secures $50M equity financing facility
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ENvue Medical Inc (FEED)
The ENvue Medical share price today is 0.3906, view NASDAQ FEED stock exchange data. Track the latest ENvue Medical share price with real-time updates on FEED stock performance including market cap, day range, 52-week range and dividend yield. Access FEED charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3906
0.4149
52 wk Range
0.2900
17.4000
FEED is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.39060.4149
52 wk Range
0.290017.4000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FEED Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
ENvue Medical completes US manufacturing transition- Investing.com
Form 8K ENvue Medical Inc For: 12 August- Investing.com
- ENvue Medical secures $50M equity financing facility
- Investing.com
- Form 8K ENvue Medical Inc For: 12 August
- Investing.com
ENvue Medical completes manufacturing shift to U.S.- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
17-08-2026
EPS / Forecast
-1.98 / --
Revenue / Forecast
239K / --
Compare FEED to Peers and Sector
Metrics to compare | FEED | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFEEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.7x | −3.8x | −0.3x | |
PEG Ratio | 0.70 | −0.17 | 0.00 | |
Price/Book | 0.1x | 3.2x | 2.6x | |
Price / LTM Sales | 1.9x | 1.8x | 3.1x | |
Upside (Analyst Target) | - | 44.1% | 47.6% | |
Fair Value Upside | Unlock | 15.3% | 5.6% | Unlock |
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. ENvue Medical, Inc. was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ENvue Medical (FEED) Share Price Today?
The ENvue Medical share price today is 0.3906.
What is the current ENvue Medical (FEED) share price and day range?
As of 21-08-2026, the ENvue Medical share price is 0.3906, with a previous close of 0.4018. The share price has ranged from 0.3906 to 0.4149 today, while the 52-week range spans from 0.2900 to 17.4000.
What Is the ENvue Medical Market Cap?
As of today, ENvue Medical market cap is 3.7400M.
What Is ENvue Medical's Earnings Per Share (TTM)?
The ENvue Medical EPS (TTM) is -17.2500.
From a Technical Analysis Perspective, Is FEED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does ENvue Medical Trade On?
ENvue Medical is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for ENvue Medical?
The stock symbol for ENvue Medical is "FEED."
How Many Times Has ENvue Medical Stock Split?
ENvue Medical has split 3 times.
How Many Employees Does ENvue Medical Have?
ENvue Medical has 13 employees.
What Is the FEED Premarket Price?
FEED's last pre-market stock price is 0.4127. The pre-market share volume is 790.0000, and the stock has changed by 0.0109, or 2.7100%.
What Is the FEED After Hours Price?
FEED's last after hours stock price is 0.3870, the stock has changed by -0.0036, or -0.9200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.